PIZZI, Marina
 Distribuzione geografica
Continente #
NA - Nord America 7.814
EU - Europa 6.492
AS - Asia 2.602
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 16
SA - Sud America 13
AF - Africa 10
AN - Antartide 1
Totale 16.966
Nazione #
US - Stati Uniti d'America 7.775
PL - Polonia 3.222
CN - Cina 1.249
UA - Ucraina 1.023
DE - Germania 634
IT - Italia 590
SG - Singapore 464
FI - Finlandia 268
GB - Regno Unito 257
HK - Hong Kong 256
IN - India 232
TR - Turchia 180
IE - Irlanda 174
FR - Francia 155
VN - Vietnam 126
ID - Indonesia 47
RU - Federazione Russa 45
BE - Belgio 39
CA - Canada 36
SE - Svezia 28
CZ - Repubblica Ceca 27
EU - Europa 16
IR - Iran 16
AU - Australia 15
KR - Corea 14
NL - Olanda 10
ES - Italia 7
CL - Cile 6
MU - Mauritius 6
BR - Brasile 4
JP - Giappone 4
RO - Romania 4
IL - Israele 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
CH - Svizzera 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
LT - Lituania 2
MX - Messico 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BO - Bolivia 1
EC - Ecuador 1
GR - Grecia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
JM - Giamaica 1
KE - Kenya 1
MK - Macedonia 1
OM - Oman 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 16.966
Città #
Warsaw 3.222
Fairfield 1.040
Woodbridge 812
Jacksonville 732
Houston 601
Ashburn 542
Ann Arbor 491
Chandler 474
Cambridge 441
Seattle 394
Wilmington 383
Singapore 368
Princeton 314
Nanjing 298
Brescia 256
Hong Kong 253
Dearborn 206
Beijing 205
Dublin 173
New York 162
Istanbul 157
Helsinki 153
Dong Ket 126
Nanchang 89
Pune 81
Shenyang 78
Des Moines 76
Hebei 71
Jinan 64
Lancaster 62
Tianjin 59
Changsha 56
Milan 56
Shanghai 55
San Diego 48
Jakarta 46
Brussels 37
Los Angeles 35
Kunming 30
London 30
Jiaxing 29
Munich 28
Ningbo 28
Toronto 23
Zhengzhou 23
Taizhou 22
Hangzhou 21
Lanzhou 21
Brno 19
San Francisco 19
Verona 19
Boardman 18
Orange 18
Guangzhou 17
Haikou 17
San Mateo 16
Phoenix 15
Romola 14
Augusta 13
Kocaeli 13
Norwalk 13
San Giuliano Milanese 13
Kilburn 12
Leawood 11
Ardabil 10
Ottawa 9
Taiyuan 9
Mumbai 8
Nürnberg 8
Pavia 8
Rome 8
Melbourne 7
Chions 6
Monmouth Junction 6
Olomouc 6
Oxford 6
Cattolica 5
Changchun 5
Chicago 5
Clifton 5
Falls Church 5
La Spezia 5
Napoli 5
Paris 5
San Donà Di Piave 5
Santa Clara 5
Seoul 5
Corridonia 4
Frankfurt am Main 4
Hefei 4
New Bedfont 4
Alzano Lombardo 3
Auckland 3
Bergamo 3
Berlin 3
Birmingham 3
Canberra 3
Central 3
Chiswick 3
Florence 3
Totale 13.407
Nome #
CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid 311
Neuroprotective and Anti-Apoptotic Effects of CSP-1103 in Primary Cortical Neurons Exposed to Oxygen and Glucose Deprivation 277
PEA and luteolin synergistically reduce mast cell-mediated toxicity and elicit neuroprotection in cell-based models of brain ischemia 268
Glutamatergic neurons induce expression of functional glutamatergic synapses in primary myotubes. 265
Glutamatergic Reinnervation and Assembly of Glutamatergic Synapses in Adult Rat Skeletal Muscle Occurs at Cholinergic Endplates 254
Dopamine transporter/α-synuclein complexes are altered in the post mortem caudate putamen of Parkinson’s disease: An in situ proximity ligation assay study 251
Glutamatergic reinnervation through peripheral nerve graft dictates assembly of glutamatergic synapses at rat skeletal muscle 250
1B/(-)IRE DMT1 Expression during Brain Ischemia Contributes to Cell Death Mediated by NF-κB/RelA Acetylation at Lys310 242
NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases 232
The End Is the Beginning: Parkinson's Disease in the Light of Brain Imaging 230
NF-κB and epigenetic mechanisms as integrative regulators of brain resilience to anoxic stress. 228
Priming of cultured neurons with sabeluzole results in long-lasting inhibition of neurotoxin-induced tau expression and cell death. 226
The Contribution of -Synuclein Spreading to Parkinson’s Disease Synaptopathy 225
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice. 220
Synergistic association of valproate and resveratrol reduces brain injury in ischemic stroke 219
Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window. 216
Mild inflammatory profile without gliosis in the c-rel deficient mouse modeling a late-onset parkinsonism 216
Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model 213
A Polyphenol-Enriched Supplement Exerts Potent Epigenetic-Protective Activity in a Cell-Based Model of Brain Ischemia 209
Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation 200
Mitochondria and alpha-synuclein: Friends or foes in the pathogenesis of Parkinson's disease? 179
Pharmacological targeting of the beta-amyloid precursor protein intracellular domain 177
NUOVO IMPIEGO TERAPEUTICO PREVENTIVO DELLA SUBUNITA' C-REL DELLA PROTEINA NF-KAPPAB E NUOVO IMPIEGO DI UN ANIMALE TRASGENICO NON UMANO CHE PORTA LA DELEZIONE DEL GENE C-REL (C-REL-/-) 165
The gamma-Secretase Modulator CHF5074 Reduces the Accumulation of Native Hyperphosphorylated Tau in a Transgenic Mouse Model of Alzheimer's Disease 159
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 156
Targeting IKK2 by pharmacological inhibitor AS602868 prevents excitotoxic injury to neurons and oligodendrocytes. 151
The Role of Mast Cells in Stroke 151
Spinal cord mGlu1a receptors - Possible target for amyotrophic lateral sclerosis therapy 150
Post-ischemic brain damage: NF-kappaB dimer heterogeneity as a molecular determinant of neuron vulnerability 148
c-Rel deficient mice, a mouse model of "spreading" PD-like pathology. 147
NF-kappaB p50/RelA and c-Rel-containing dimers: opposite regulators of neuron vulnerability to ischaemia. 145
Bim and Noxa are candidates to mediate the deleterious effect of the NF-kappa B subunit RelA in cerebral ischemia. 145
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 143
NF-κB/c-Rel deficiency causes Parkinson's disease-like prodromal symptoms and progressive pathology in mice 139
Chapter 24 NF-KappaB Dimers in the Regulation of Neuronal Survival 137
A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release. 130
A Tau antisense oligonucleotide decreases neurone sensitivity to excitotoxic injury. 129
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate 127
N-methyl-D-aspartate neurotoxicity in hippocampal slices: protection by aniracetam. 127
Cellular mechanisms for neurotensin receptor-mediated release of prolactin. 126
Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line 124
Activation of dopamine D2 receptors linked to voltage-sensitive potassium channels reduces forskolin-induced cyclic AMP formation in rat pituitary cells. 124
Antisense strategy unravels tau proteins as molecular risk factors for glutamate-induced neurodegeneration. 120
Activation of multiple metabotropic glutamate receptor subtypes prevents NMDA-induced excitotoxicity in rat hippocampal slices. 115
Inhibition of glutamate-induced neurotoxicity by a tau antisense oligonucleotide in primary culture of rat cerebellar granule cells 114
The gamma-secretase modulator CHF5074 elicits neuroprotection and increases histone acetylation in primary cortical neurons exposed to oxygen glucose deprivation 112
Pharmacological basis for dopamine D-2 receptor diversity 112
Synapsin III alterations in Parkinson's disease 111
Electrophysiological and metabolic effects of CHF5074 in the hippocampus: protection against in vitro ischemia. 110
Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells. 109
Tolerance to hypoactivity and sensitization to hyperactivity after chronic treatment with a presynaptic dose of lisuride in rats 108
Synergistic association of valproate and resveratrol reduces brain injury in ischemic stroke. 108
SYNERGIC ROLE OF RESVERATROL AND HDACi MS-275 IN NEUROPROTECTION 107
Mitochondrial Dysfunction and Alpha-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First? 107
c-Rel deficient mice, a mouse model of “spreading” PD-like pathology 107
EXACERBATED AGE-DEPENDENT LOSS OF NIGRAL DOPAMINERGIC NEURONS IN NF-KAPPAB C-REL -/- MICE 107
α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons 106
Post-synaptic D1 and D2 dopamine receptors are present in rabbit renal and mesenteric arteries 105
The differential coupling mechanism of dopamine D-2 receptor subtypes: importance for the actions of neuroleptic drugs 105
Repeated administration of (−) sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions 105
Various Ca2+ entry blockers prevent glutamate-induced neurotoxicity. 104
Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol. 103
Dopamine D2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices. 103
Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices 102
Cortical neurons induce the expression of glutamate receptors in primary myotubes 102
Differential expression of fetal and mature tau isoforms in primary cultures of rat cerebellar granule cells during differentiation in vitro 102
Spinal cord mGlu1a receptors: possible target for amyotrophic lateral sclerosis therapy. 102
Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells. 102
Properties of benzodiazepine binding sites in peripheral blood lymphocytes 101
Degenerazione età –dipendente dei neuroni dopaminergici della sostanza nera nei topi NF-kappaB cRel 100
Lack of vasoactive intestinal peptide-releasing property in prolactin cells from ovariectomized rats: contribution of post-transductional impairments 100
Inhibition of IκBα phosphorylation prevents glutamate-induced NF-κB activation and neuronal cell death 100
The inhibitor of IkappaBalpha phosphorylation BAY 11-7082 prevents NMDA neurotoxicity in mouse hippocampal slices. 99
Differential pattern of expression of G proteins in nucleus striatum from 6-hydroxydopamine lesioned rats. 99
Opposing regulation of amyloid precursor protein by ionotropic and metabotropic glutamate receptors. 98
An in vitro method of diagnosing Parkinson's disease 98
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease 96
A bioinformatics analysis of memory consolidation reveals involvement of the transcription factor c-rel. 95
Peripheral and central mechanisms of action of serotoninergic anorectic drugs. 95
Differential expression of fetal and mature tau isoforms in primary cultures of rat cerebellar granule cells during differentiation in vitro. 94
Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells. 94
Neuroprotection by metabotropic glutamate receptor agonists on kainate-induced degeneration of motor neurons in spinal cord slices from adult rat. 94
Acetylation of NF-kappaB p50/RelA and histones in the epigenetic regulation of pro-apoptotic transcription: a neuroprotective target in brain ischemia 93
Differential up-regulation of D-1 and D-2 dopamine receptor function in mesostriatal areas but not in cortical-limbic brain regions of rats chronically treated with (?)sulpiride and SCH 23390 93
Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation 92
Glutamatergic innervation of rat skeletal muscle by supraspinal neurons: a new paradigm in spinal cord injury repair 91
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 91
Group-I metabotropic glutamate receptors: hypotheses to explain their dual role in neurotoxicity and neuroprotection. 88
Molecular mechanisms of glutamate-induced neurodegeneration 88
Reversal of glutamate excitotoxicity by activation of PKC-associated metabotropic glutamate receptors in cerebellar granule cells relies on NR2C subunit expression 87
The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury. 85
Possible new targets for GPCR modulation: allosteric interactions, plasma membrane domains, intercellular transfer and epigenetic mechanisms 85
Evidence for the presence of D2 but not D1 dopamine receptors in rat hypothalamic perifornical area. 85
Targeting epigenetic regulation of NF-KappaB and histones in the therapy of post-ischemic brain injury 81
Leptin Is Induced in the Ischemic Cerebral Cortex and Exerts Neuroprotection Through NF-{kappa}B/c-Rel-Dependent Transcription. 80
ACETYLATION OF NF-KAPPAB p65 IN THE EPIGENETIC REGULATION OF TRANSCRIPTION: A NEUROPROTECTIVE TARGET IN BRAIN ISCHEMIA 80
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionate and kainate differently affect neuronal cytoarchitecture of rat cerebellar granule cells 80
Blockade of the tumor necrosis factor-related apoptosis inducing ligand death receptor DR5 prevents beta-amyloid neurotoxicity. 79
Parkinson's disease: from synaptic loss to connectome dysfunction 79
Involvement of Synapsin III in the onset of Alpha-synuclein pathology in Parkinson’s Disease 79
Totale 13.618
Categoria #
all - tutte 75.903
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.903


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.095 0 0 0 0 0 576 451 529 345 714 219 261
2020/20212.949 94 320 98 362 120 293 190 336 404 267 279 186
2021/20221.396 121 272 25 37 25 64 87 77 70 181 129 308
2022/20231.311 187 34 56 102 134 329 3 132 192 27 58 57
2023/20241.384 92 34 120 82 68 325 55 66 276 31 33 202
2024/2025862 24 44 34 408 344 8 0 0 0 0 0 0
Totale 17.524